We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Steven Rowe

Steven P Rowe MD, PhD

Resident, Division of Nuclear Medicine and Molecular Imaging of The Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University School of Medicine, Baltimore, MD

Steven P. Rowe, M.D., Ph.D. is a resident in the Division of Nuclear Medicine and Molecular Imaging of The Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University School of Medicine, Baltimore, Maryland. His research is focused on molecular imaging of genitourinary cancers and he has published a number of papers on PSMA-targeted PET agents and their applicability in both prostate cancer and clear cell renal cell carcinoma. 

Disclosures

He has no relevant disclosures.